Team Europe: Mongolia receives COVID-19 vaccine through the COVAX Facility www.eeas.europa.eu
The first consignment of COVID-19 vaccines from the multilateral COVAX Facility have been delivered to Mongolia. These 14 400 doses are part of a first wave of arrival that will continue in the coming months. Mongolia will receive 138 540 doses of the vaccines under the COVAX Facility.
"The COVAX Facility is a great illustration of global solidarity. This is real multilateralism in action. The European Union is proud to join the Government of Mongolia, the UN agencies and bilateral donors to make this happen. Team Europe - the EU, its Member States and financial institutions - are a leading contributor to the COVAX Facility with more than EUR 2.2 billion. The first batch of vaccines is only the beginning. There will be much more. Making sure everyone has access to safe and effective COVID-19 vaccines is a top priority of the European Union." Said H.E. Traian Hristea, Ambassador of the European Union to Mongolia.
It is a key priority for the European Union to help end the pandemic by enabling fair, equitable, safe and effective global access to COVID-19 vaccines. This contribution will help secure 1.3 billion doses of vaccination for 92 low and middle-income countries, including Mongolia by the end of the year.
As the EU High Representative Joseph Borrell has said, the coronavirus is "the world's common enemy that we can only defeat with a global approach". Team Europe has mobilised significant resources also to help our partners across the world address the immediate health emergency, support health systems and the economic recovery.
The COVAX Facility aims to deliver at least 2 billion doses before the end of this year, of which 1.3 billion to 92 countries that are eligible for such support. The EU and its Member States are committed to this unprecedented global effort to make sure all citizens have access to safe and effective vaccines.
COVAX is co-led by GAVI, the Vaccine Alliance, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI), working in partnership with UNICEF, civil society organisations, manufacturers and others stakeholders.
The COVAX Facility is a risk-sharing mechanism: it reduces the risk for manufacturers who invest without being sure about future demand, and it reduces the risk that countries would fail to secure access to a viable vaccine.
Team Europe - the EU, its Member States and the European Investment Bank - is a leading contributor to this multilateral initiative, with over EUR 2.2/USD 2.6 billion. The EU contribution as a whole brings us closer to achieving the COVAX target.
For further information, contact: delegation-mongolia-press@eeas.europa.eu
Published Date:2021-03-14